There are only 15 days left to secure the 10% Early Bird discount for BIOCHINA BiOPartnering. The program offers structured 1V1 meetings designed to support targeted business discussions and partnership development with global biopharma companies.

Registration : https://lnkd.in/gPCupCrS

BIOCHINA 2026 will take place in Suzhou, China, in March 2026, bringing together a strong delegation of international pharmaceutical leaders. Leading Big Pharma companies, including Bayer, Eli Lilly, Pfizer, Novartis, BMS, Hikma, Dr. Reddy’s, and others, have confirmed their participation. These companies are forming dedicated teams to actively source innovation projects from China, spanning biologics, innovative drugs, and enabling technologies.

Through the BiOPartnering system, participants can review current 1V1 meeting opportunities, explore specific collaboration interests, and schedule focused discussions in advance.

BIOCHINA provides a professional platform for cross-border business development, enabling efficient connections between global pharma companies and Chinese innovation-driven partners.

Secure your spot now and connect with global pharma leaders at BIOCHINA 2026.